However, LSEC capillarization is known to precede fibrogenesis in different kinds of liver diseases including NAFLD and NASH[59] and the circulating level of A‐FABP is positively correlated to the fibrosis stages in patients with NASH.[13] Thus, the role of A‐FABP in fibrogenesis during the progression of NASH warrants further investigation. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.